- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Português (Portugal)
- Polski
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
CVRx Inc (CVRX)"CVRx Inc stock price live, this page displays NASDAQ CVRX stock exchange data. View the CVRX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the CVRx Inc real time stock price chart below.
What Is the CVRx Inc Stock Price Today?
The CVRx Inc stock price today is 13.48.
What Is the Stock Symbol for CVRx Inc?
The stock symbol for CVRx Inc is ""CVRX.""
What Stock Exchange Does CVRx Inc Trade On?
CVRx Inc is listed and trades on the NASDAQ stock exchange.
Is CVRx Inc a Good Stock to Buy?
Determining whether CVRx Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CVRX quote. (ISIN: US1266381052)"
What Is the CVRx Inc Stock Price Today?
The CVRx Inc stock price today is 13.48.
What Is the Stock Symbol for CVRx Inc?
The stock symbol for CVRx Inc is ""CVRX.""
What Stock Exchange Does CVRx Inc Trade On?
CVRx Inc is listed and trades on the NASDAQ stock exchange.
Is CVRx Inc a Good Stock to Buy?
Determining whether CVRx Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the CVRX quote. (ISIN: US1266381052)"
13.48
+0.08(+0.60%)
Closed
After Hours
13.480.00(0.00%)
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
13.42
13.82
52 wk Range
6.40
33.14
CVRX Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
13.4213.82
52 wk Range
6.4033.14
Key Statistics
Edit
Book Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockBook Value / Share
UnlockFair Value
UnlockFair Value Upside
UnlockEPS Growth Forecast
UnlockN/A
(N/A)
Dividends Payment Streak
UnlockEBITDA
UnlockEV/EBITDA
UnlockCVRX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceFair Price
Upside
Price Target
17.33
Upside
+28.56%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock has taken a big hit over the last week
- CVRx gains CMS payment classification for Barostim
- Investing.com
- CVRx receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- CVRx receives Investment Bank Analyst Rating Update
- Investing.com
Pro - CVRx receives Investment Bank Analyst Rating Update
- Investing.com
Pro - CVRx gains CMS payment classification for Barostim
- Investing.com
CVRx Inc Company Profile
CVRx, Inc., a commercial-stage medical device company, focuses on developing, manufacturing, and commercializing neuromodulation solutions for patients with cardiovascular diseases. The company offers Barostim, a neuromodulation device indicated to improve symptoms for patients with heart failure with reduced ejection fraction or systolic heart failure. It sells its products through direct sales force, as well as sales agents and independent distributors in the United States, Germany, and internationally. The company was incorporated in 2000 and is headquartered in Minneapolis, Minnesota.
CVRx Inc SWOT Analysis
Reimbursement Pivot | CVRx awaits crucial decision on outpatient reimbursement rates for Barostim, potentially impacting financial performance and stock value |
Barostim's Significance | Explore CVRx's neurostimulation-based treatment for heart failure and hypertension, with 85-90% of procedures performed in outpatient settings |
Market Volatility | CVRx stock fluctuates between $6.40 and $33.13, reflecting market uncertainty amid pending reimbursement decision |
Analyst Optimism | Delve into Canaccord Genuity's BUY rating with a $15 price target, highlighting potential upside despite regulatory challenges |
CVRX Full Pro Research
Institutional-Grade Stock Analysis
Understand how CVRX earns money
Financial health at a glance
Bearish and bullish outlooks
Latest expert insights
Actionable Pro Tips, and many more...
Gain access to 1400+ in-depth research reports on the most popular US stocks
CVRx Inc Earnings Call Summary for Q4/2024
- Q3 revenue up 27% to $13.4M, driven by US Heart Failure; net loss $13.1M ($0.57/share)
- Reimbursement wins: higher DRG payment, Category 1 CPT codes for Barostim therapy
- 2024 revenue forecast: $50.5M-$51.5M; Q4 projection: $14.5M-$15.5M
- $100.2M cash on hand; $20M loan and $20.3M equity offering strengthen balance sheet
- Focus on Barostim as standard care; optimistic about cash flow breakeven and 20%+ growth
Last Updated: 2024/10/30, 21:56
Read Full TranscriptCompare CVRX to Peers and Sector
Metrics to compare | CVRX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCVRXPeersSector | |
|---|---|---|---|---|
P/E Ratio | −5.6x | −5.5x | −0.7x | |
PEG Ratio | 0.18 | −0.01 | 0.00 | |
Price/Book | 5.0x | 1.7x | 2.6x | |
Price / LTM Sales | 6.9x | 1.9x | 3.2x | |
Upside (Analyst Target) | 33.5% | 31.0% | 46.6% | |
Fair Value Upside | Unlock | 12.2% | 7.4% | Unlock |
Analysts' Recommendations
5 Buy
2 Hold
0 Sell
Ratings:
6 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 17.33
(+28.59% Upside)
FAQ
What Is the CVRx (CVRX) Stock Price Today?
The CVRx stock price today is 13.48
What Stock Exchange Does CVRx Trade On?
CVRx is listed and trades on the NASDAQ stock exchange.
What Is the Stock Symbol for CVRx?
The stock symbol for CVRx is "CVRX."
What Is the CVRx Market Cap?
As of today, CVRx market cap is 327.07M.
What is CVRx Earnings Per Share?
The CVRx EPS is -2.70.
What Is the Next CVRx Earnings Date?
CVRx will release its next earnings report on 22 Jan 2025.
From a Technical Analysis Perspective, Is CVRX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.